Pfizer and Moderna Analysis Re-do
Peter Doshi and colleagues' heroic attempt at re-analysis of the Phase 3 trials
There has been a bit of a stir lately concerning the posting at the beginning of this month of a pre-print (not yet peer reviewed) article entitled “Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials”.
Words like “bombshell study” have been used to describe the findings. That sounds pretty significant, and certain…